D.E. Shaw & Co
ELGX

D.E. Shaw & Co’s Endologix Inc ELGX Stock Holding History

D.E. Shaw & Co’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-145,227
Closed -$229K – 4478
2019
Q4 		$229K Buy
145,227
+66,815
+85% +$187K ﹤0.01% 3748
2019
Q3 		$311K Sell
78,412
-99,519
-56% -$579K ﹤0.01% 3446
2019
Q2 		$1.29M Buy
177,931
+11,497
+7% +$78.4K ﹤0.01% 2527
2019
Q1 		$1.1M Sell
166,434
-27,749
-14% -$183K ﹤0.01% 2553
2018
Q4 		$1.39M Buy
194,183
+28,637
+17% +$319K ﹤0.01% 2432
2018
Q3 		$3.16M Buy
165,546
+3,149
+2% +$112K ﹤0.01% 1884
2018
Q2 		$9.19M Sell
162,397
-3,902
-2% -$198K 0.01% 1127
2018
Q1 		$7.03M Buy
166,299
+30,830
+23% +$1.32M 0.01% 1197
2017
Q4 		$7.25M Buy
135,469
+13,024
+11% +$688K 0.01% 1235
2017
Q3 		$5.46M Buy
122,445
+20,424
+20% +$931K 0.01% 1312
2017
Q2 		$4.96M Buy
102,021
+3,506
+4% +$206K 0.01% 1340
2017
Q1 		$7.13M Buy
+98,515
New +$6.52M 0.01% 1058
2016
Q3 		– Sell
-3,702
Closed -$461K – 3654
2016
Q2 		$461K Sell
3,702
-88
-2% -$10.1K ﹤0.01% 2826
2016
Q1 		$317K Sell
3,790
-5,165
-58% -$426K ﹤0.01% 2997
2015
Q4 		$887K Sell
8,955
-16,971
-65% -$1.82M ﹤0.01% 2723
2015
Q3 		$3.18M Buy
25,926
+8,553
+49% +$1.16M ﹤0.01% 1735
2015
Q2 		$2.67M Buy
17,373
+14,255
+457% +$2.35M ﹤0.01% 1967
2015
Q1 		$532K Sell
3,118
-3,704
-54% -$561K ﹤0.01% 3019
2014
Q4 		$1.04M Buy
+6,822
New +$852K ﹤0.01% 2795
2014
Q1 		– Sell
-2,169
Closed -$378K – 4799
2013
Q4 		$378K Buy
+2,169
New +$373K ﹤0.01% 3903

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

D.E. Shaw & Co's ELGX Position: Q1 2020 in Review

D.E. Shaw & Co sold out of Endologix Inc (ELGX) in Q1 2020, closing a stake of 145,227 shares — an estimated $229K sold.

D.E. Shaw & Co first reported a position in ELGX in Q4 2013 and held it in 20 quarters. The position peaked at $9.19M in Q2 2018. 50 funds tracked by Wall St. Rank hold ELGX as of Q1 2020.

  • D.E. Shaw & Co reported no remaining Endologix Inc position as of Q1 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 145,227 Endologix Inc shares in Q1 2020, an estimated $229K.
  • D.E. Shaw & Co first reported a position in Endologix Inc in Q4 2013 and held it in 20 quarters.
  • D.E. Shaw & Co's Endologix Inc position peaked at $9.19M in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.